![](https://www.i-mak.org/wp-content/uploads/2023/02/Stop-Big-Pharma-Drug-Prices.webp)
Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
Jan 2023: Patent Reform And Lower Drug Prices Should Be Bipartisan Priorities
Patent reform and lower drug prices should be bipartisan priorities
How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
Dec 2022: Year in Review – Historic Progress on Patent Reform
How AbbVie denied Americans access to fair competition for Humira
Nov 2022: MacArthur, Growing Momentum, and Much More
Life-Changing Drug Costs Over $3,000 in US, $0 to $225 in Europe
Oct 2022: How excessive pharmaceutical patenting is extending monopolies and driving up drug prices.
Report pulls no punches in critique of drug patent abuse
Partner with us now to build
a more just and equitable
medicine system for all.